SWOG Cancer Research Network: Prostatic Neoplasms trials

The registry lists 19 Prostatic Neoplasms studies with SWOG Cancer Research Network as lead sponsor. 3 are open to participants now and 9 have results posted.

Phase 1 2Phase 2 5Phase 3 9No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the BodyRecruitingNCT06470243Phase 3
• Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene MutationRecruitingNCT05806515Phase 2
• Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerRecruitingNCT03678025Phase 3
• S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate CancerCompletedNCT01809691Phase 3Results posted
• S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone TherapyCompletedNCT01309672Phase 2Results posted
• S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT00433446Phase 2Results posted
• S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone TherapyCompletedNCT00134056Phase 3Results posted
• S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the ProstateCompletedNCT00030901Phase 3Results posted
• S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate CancerCompletedNCT00028769Phase 2Results posted
• S0000 Selenium and Vitamin E in Preventing Prostate CancerCompletedNCT00006392Phase 3Results posted
• S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate CancerCompletedNCT00004124Phase 3Results posted
• SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate CancerCompletedNCT00002651Phase 3Results posted
• S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and GoserelinCompletedNCT01120262
• S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid TumorsWithdrawnNCT00937417Phase 1
• S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone MetastasesCompletedNCT00874211
• S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPTTerminatedNCT00288106
• S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian CancerTerminatedNCT00023634Phase 1
• BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00016393Phase 2
• S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00004001Phase 3